María Gómez‐Cañas
0000-0002-2520-948X
Publication & Citation Trends
Publications
40 total
Benefits of VCE-003.2, a cannabigerol quinone derivative, against inflammation-driven neuronal deterioration in experimental Parkinson’s disease: possible involvement of different binding sites at the PPARγ receptor PDF
Cited by 64
OpenAlex
The cannabinoid quinol VCE-004.8 alleviates bleomycin-induced scleroderma and exerts potent antifibrotic effects through peroxisome proliferator-activated receptor-γ and CB2 pathways PDF
Cited by 91
OpenAlex
Chromenopyrazole, a Versatile Cannabinoid Scaffold with in Vivo Activity in a Model of Multiple Sclerosis PDF
Cited by 47
OpenAlex
Prenatal exposure to cannabinoids evokes long-lasting functional alterations by targeting CB <sub>1</sub> receptors on developing cortical neurons PDF
Cited by 153
OpenAlex
Selective, Nontoxic CB<sub>2</sub> Cannabinoid <i>o</i>-Quinone with in Vivo Activity against Triple-Negative Breast Cancer PDF
Cited by 38
OpenAlex
Cannabinoid agonists showing BuChE inhibition as potential therapeutic agents for Alzheimer's disease PDF
Cited by 50
OpenAlex
Synthetic cannabinoid quinones: Preparation, in vitro antiproliferative effects and in vivo prostate antitumor activity PDF
Cited by 47
OpenAlex
Research Topics
Cannabis and Cannabinoid Research
(32)
Neuroscience and Neuropharmacology Research
(14)
Pharmacological Receptor Mechanisms and Effects
(11)
Neurotransmitter Receptor Influence on Behavior
(8)
Parkinson's Disease Mechanisms and Treatments
(5)
Affiliations
Universidad Complutense de Madrid
Instituto de Salud Carlos III
Biomedical Research Networking Center on Neurodegenerative Diseases
Centro de Investigación Biomédica en Red
Instituto Ramón y Cajal de Investigación Sanitaria